Aimei Health Technology Stock Shares Owned By Insiders

AFJK Stock   10.60  0.01  0.09%   
Aimei Health Technology fundamentals help investors to digest information that contributes to Aimei Health's financial success or failures. It also enables traders to predict the movement of Aimei Stock. The fundamental analysis module provides a way to measure Aimei Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aimei Health stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Aimei Health Technology Company Shares Owned By Insiders Analysis

Aimei Health's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Insiders Shares

 = 

Executives Shares

+

Employees

More About Shares Owned By Insiders | All Equity Analysis

Current Aimei Health Shares Owned By Insiders

    
  22.70 %  
Most of Aimei Health's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aimei Health Technology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition

Based on the latest financial disclosure, 22.7% of Aimei Health Technology are shares owned by insiders. This is 141.49% higher than that of the Life Sciences Tools & Services sector and significantly higher than that of the Health Care industry. The shares owned by insiders for all United States stocks is 124.98% lower than that of the firm.

Aimei Shares Owned By Insiders Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aimei Health's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aimei Health could also be used in its relative valuation, which is a method of valuing Aimei Health by comparing valuation metrics of similar companies.
Aimei Health is currently under evaluation in shares owned by insiders category among its peers.

Aimei Health ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Aimei Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Aimei Health's managers, analysts, and investors.
Environmental
Governance
Social

Aimei Fundamentals

About Aimei Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Aimei Health Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aimei Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aimei Health Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Aimei Health Technology is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Aimei Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Aimei Health Technology Stock. Highlighted below are key reports to facilitate an investment decision about Aimei Health Technology Stock:
Check out Aimei Health Piotroski F Score and Aimei Health Altman Z Score analysis.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aimei Health. If investors know Aimei will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aimei Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aimei Health Technology is measured differently than its book value, which is the value of Aimei that is recorded on the company's balance sheet. Investors also form their own opinion of Aimei Health's value that differs from its market value or its book value, called intrinsic value, which is Aimei Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aimei Health's market value can be influenced by many factors that don't directly affect Aimei Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aimei Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aimei Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aimei Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.